Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings preview of WBA stock now.

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens Boots Alliance (WBA) to be acquired by Sycamore Partners at $11.45/share plus potential extras. Explore shareholder options and expert insights.

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

US Stock futures ticked higher early Thursday, with the S&P 500 now just shy of its all-time high, gaining 0.3% in pre-market trading. The Nasdaq 100 futures rose 0.4%, while Dow Jones futures added ...

The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.

Walgreens Boots Alliance (NASDAQ:WBA) reported stronger-than-expected earnings and revenue for its fiscal third quarter, as cost-cutting measures helped offset weakness in front-of-store sales. The ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2025, which ended May 31, 2025.